Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;62(2):125-141.
doi: 10.1002/jcph.1633. Epub 2020 Oct 26.

Parametric Approaches in Population Pharmacokinetics

Monia Guidi  1   2 , Chantal Csajka  1   3 , Thierry Buclin  2
Affiliations
Review

Parametric Approaches in Population Pharmacokinetics

Monia Guidi et al. J Clin Pharmacol. 2022 Feb.

Abstract

Population pharmacokinetic (popPK) approaches have spread widely throughout clinical pharmacology research, and every clinician should have some understanding of them. After a general introduction on the fundamentals and fields of application of these approaches, this review focuses on parametric popPK methods to provide the clinicians with the conceptual tools to interpret appropriately the results of parametric popPK analyses and to understand their clinical utility. The emphasis is put on the clinical questions that popPK methods are best suited to address. The basic principles of the methodology are introduced first, and then the main algorithms and reference software programs used in such analyses are presented. The description of data analysis and clinical applications of the parametric popPK approach (ie, use in simulations and therapeutic drug monitoring) are illustrated with the example of the antiretroviral drug efavirenz.

Keywords: clinical pharmacology (CPH); drug development; education (EDU); modeling & simulation; population pharmacokinetics.

PubMed Disclaimer

References

    1. Aarons L. Population pharmacokinetics: theory and practice. Br J Clin Pharmacol. 1991;32(6):669-670.
    1. Steimer JL. Population models and methods, with emphasis on pharmacokinetics. In: Rowland M, Aarons L, eds. New Strategies in Drug Development and Clinical Evaluation: The Population Approach. Luxembourg: Commision of the EuopeanCommunities; 1992:31-40.
    1. Williams PJ, Ette EI. Pharmacometric: impacting drug development and pharmacotherapy. In: Ette EI, Williams PJ, eds. Pharmacometrics: The Science of Quantitative Pharmacology. Hoboken, NJ: John Wiley & Sons; 2007:1-21.
    1. Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res. 1972;5(5):411-459.
    1. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977;5(5):445-479.

LinkOut - more resources